Pre-made Zenocutuzumab benchmark antibody ( Bispecific mAb, anti-ERBB3/Erbb-3;ERBB2/HER2 therapeutic antibody, Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-645

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-645 Category Tags ,

Product Details

Pre-Made Zenocutuzumab biosimilar, Bispecific mAb, Anti-ERBB3/Erbb-3;ERBB2/HER2 Antibody: Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Zenocutuzumab biosimilar, Bispecific mAb, Anti-ERBB3/Erbb-3;ERBB2/HER2 Antibody: Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN 19/NEU/NG

INN Name

Zenocutuzumab

Target

ERBB3,ERBB2

Format

Bispecific mAb

Derivation

Bispecific antibody

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa,Kappa

Highest_Clin_Trial (Jan '20)

Phase-II

Est. Status

Active

100% SI Structure

5o4o:BA/5o7p:BA;5o4g:BA

99% SI Structure

None;None

95-98% SI Structure

None;None

Year Proposed

2017

Companies

Merus

Conditions Approved

NA

Conditions Active

Breast cancer,Colorectal cancer,Gastric cancer,Non-small cell lung cancer

Conditions Discontinued

Endometrial cancer,Ovarian cancer

Development Tech

Common light chain method ( the same single light chain, different heavy chain, screened by phage library) Bispecific mab by KIH-like modifications in CH3 of heavy chain, L351D and L368E in one, L351

Previous Name

NA

Gm Offical Target Name

ERBB3,ERBB2

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide